{"id":238526,"date":"2026-09-09T15:27:40","date_gmt":"2026-09-09T09:57:40","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=238526"},"modified":"2026-09-09T15:27:40","modified_gmt":"2026-09-09T09:57:40","slug":"why-gujarat-themis-biosyn-share-price-fall-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/","title":{"rendered":"Gujarat Themis Biosyn (GUJTHEM) Share Price Falls 5.07% Today"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/gujthem\/gujarat-themis-biosyn-ltd-share-price-today\">Gujarat Themis Biosyn (GUJTHEM)<\/a>share price fell to Rs 430.15 today, down 5.07% from the previous close. Market cap was Rs 5,897.17 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\">Gujarat Themis Biosyn Share Price fell to Rs 430.15 today, down 5.07% or Rs 22.95 from the previous close of Rs 453.10. The company\u2019s market capitalisation stood at Rs 5,897.17 crore. The Mid Cap pharmaceutical stock opened at Rs 463.00, touched a day high of Rs 463.00 and slipped to a day low of Rs 427.55, placing the counter in focus during the session.<\/p>\n<p>The supplied data confirms a sharp single-day decline, but it does not establish any company-specific trigger. That is an important distinction. The current discussion is driven by verified market data such as price action, valuation and sector comparison, not by a disclosed catalyst in the dataset.<\/p>\n<p>For investors tracking Gujarat Themis Biosyn Share Price today, the immediate picture is clear: the stock saw notable intraday weakness, turnover came in at Rs 1.57 crore, valuation remains elevated versus industry benchmarks, and profitability ratios still look stronger than broader sector medians. The practical question after such a move is whether the market continues to support premium multiples after this pullback.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#Gujarat_Themis_Biosyn_GUJTHEM_Share_Price_Today_Price_Action_Analysis\" title=\"Gujarat Themis Biosyn (GUJTHEM) Share Price Today: Price Action Analysis\">Gujarat Themis Biosyn (GUJTHEM) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#Gujarat_Themis_Biosyn_GUJTHEM_Fundamental_Analysis\" title=\"Gujarat Themis Biosyn (GUJTHEM) Fundamental Analysis\">Gujarat Themis Biosyn (GUJTHEM) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#Why_Investors_Are_Watching_Gujarat_Themis_Biosyn\" title=\"Why Investors Are Watching Gujarat Themis Biosyn\">Why Investors Are Watching Gujarat Themis Biosyn<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#About_Gujarat_Themis_Biosyn\" title=\"About Gujarat Themis Biosyn\">About Gujarat Themis Biosyn<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#Track_Gujarat_Themis_Biosyn_Share_Price_on_Univest\" title=\"Track Gujarat Themis Biosyn Share Price on Univest\">Track Gujarat Themis Biosyn Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#Why_is_Gujarat_Themis_Biosyn_Share_Price_falling_today\" title=\"Why is Gujarat Themis Biosyn Share Price falling today?\">Why is Gujarat Themis Biosyn Share Price falling today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#What_is_Gujarat_Themis_Biosyn_Share_Price_today\" title=\"What is Gujarat Themis Biosyn Share Price today?\">What is Gujarat Themis Biosyn Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#What_does_the_intraday_move_show_for_GUJTHEM\" title=\"What does the intraday move show for GUJTHEM?\">What does the intraday move show for GUJTHEM?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#How_is_the_stock_valued_versus_its_industry\" title=\"How is the stock valued versus its industry?\">How is the stock valued versus its industry?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#Are_its_profitability_ratios_strong\" title=\"Are its profitability ratios strong?\">Are its profitability ratios strong?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#How_does_it_compare_with_major_pharma_peers\" title=\"How does it compare with major pharma peers?\">How does it compare with major pharma peers?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Gujarat_Themis_Biosyn_GUJTHEM_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Gujarat Themis Biosyn (GUJTHEM) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 430.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 453.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 22.95 (-5.07%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 463<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 463<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 427.55<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1.57 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,897.17 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Mid Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The intraday structure was weak. The stock opened at Rs 463.00, which also remained the session high, and then moved down to Rs 427.55 before trading at Rs 430.15 at the time of the update. When the opening price also marks the day\u2019s high, it generally indicates that sellers had control after the first print and the stock did not reclaim early levels during the session.<\/p>\n<p>The decline of 5.07% is large enough to attract attention on its own, especially in a Mid Cap name. Turnover of Rs 1.57 crore indicates that the price move came with active trading rather than a static quote. Even so, the dataset does not explain the reason for the move, so any analysis must stay anchored to what is confirmed: the stock fell, the range was wide, and the closing trade at the update remained much closer to the day\u2019s low than the high.<\/p>\n<p>From a monitoring perspective, this leaves investors watching whether the stock stabilises around current levels or whether the pressure extends further. Without a stated trigger, market participants are more likely to judge the move through valuation, technical positioning and comparison with industry peers.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Gujarat_Themis_Biosyn_GUJTHEM_Fundamental_Analysis\"><\/span><strong>Gujarat Themis Biosyn (GUJTHEM) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,897.17 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">121.12x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.62x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.69%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.48%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3.74<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 80.59<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.15%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The fundamental picture is not one-dimensional. Gujarat Themis Biosyn has a market cap of Rs 5,897.17 crore, a P\/E ratio of 121.12 and a P\/B ratio of 5.62. Those valuation numbers are high in absolute terms. At the same time, profitability metrics are firm, with ROE at 21.69% and ROCE at 27.48%.<\/p>\n<p>EPS stands at Rs 3.74, while book value per share is Rs 80.59. The dividend yield is 0.15%, which points to a modest payout relative to the prevailing market price. Put together, these numbers show a company where the market is assigning a premium multiple to earnings and net worth, while also rewarding relatively strong return ratios.<\/p>\n<p>That is why today\u2019s decline does not automatically signal weak fundamentals from the supplied dataset. Instead, it sharpens the debate around valuation support. When a stock trades at a rich multiple, even a single day of price weakness can lead investors to reassess how much optimism is already built into the quote.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">121.12x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.19x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49.13x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.39x to 668.68x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.62x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.05x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.44x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.69%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.82%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.12%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.48%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.71%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.62%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,897.17 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 715.6 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,150.82 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Gujarat Themis Biosyn operates in Healthcare under Pharmaceuticals &amp; Drugs, and the benchmark set covers 201 companies from the same industry. Within that universe, its P\/E of 121.12 sits well above the median of 32.19 and the average of 49.13. Its P\/B of 5.62 is also above the median of 3.05 and the average of 4.44.<\/p>\n<p>Profitability is where the comparison turns more favourable. ROE of 21.69% is ahead of the industry median of 11.82% and average of 11.12%. ROCE of 27.48% is similarly above the median of 13.71% and average of 13.62%. So the stock does not screen as expensive without support from return ratios; rather, it screens as premium-valued alongside stronger-than-average profitability.<\/p>\n<p>On size, the company\u2019s market capitalisation is above the industry median of Rs 715.60 crore but below the average of Rs 14,150.82 crore. That places it in the middle of a very broad listed pharma landscape: larger than many smaller companies in the set, yet much smaller than the biggest established sector names.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,55,825.66<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">37.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Divi&#39;s Laboratories<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,47,018.51<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">86.86<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.38<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,86,874.73<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">86.55<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.03<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,15,211.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.42<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.25<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,12,773<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The peer set underlines why the valuation conversation matters. Gujarat Themis Biosyn trades at a P\/E of 121.12, above Sun Pharma at 37.31, Divi&#8217;s Laboratories at 86.86, Torrent Pharmaceuticals at 86.55, Zydus Lifesciences at 25.42 and Cipla at 33.17. That makes its earnings multiple richer than every peer listed in this comparison.<\/p>\n<p>On P\/B, the company\u2019s 5.62 is close to Sun Pharma\u2019s 5.22, above Zydus Lifesciences at 4.25 and Cipla at 3.18, but below Divi&#8217;s Laboratories at 14.38 and Torrent Pharmaceuticals at 21.03. Profitability remains a relative strength: ROE of 21.69% is above Sun Pharma, Divi&#8217;s, Zydus and Cipla, though below Torrent Pharmaceuticals at 26.76. ROCE of 27.48% is stronger than each of the five peers shown here.<\/p>\n<p>The gap appears most clearly in scale. Gujarat Themis Biosyn\u2019s market cap of Rs 5,897.17 crore is far smaller than all five peers. In other words, the stock combines smaller size with premium valuation and strong return metrics, a mix that can draw attention in both strong and weak market sessions.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Gujarat_Themis_Biosyn\"><\/span><strong>Why Investors Are Watching Gujarat Themis Biosyn<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Gujarat Themis Biosyn Share Price fell 5.07% today to Rs 430.15 from Rs 453.10.<\/li>\n<li>The stock opened at Rs 463.00, hit a low of Rs 427.55 and recorded turnover of Rs 1.57 crore.<\/li>\n<li>Its P\/E of 121.12 and P\/B of 5.62 are above industry median and average levels.<\/li>\n<li>ROE of 21.69% and ROCE of 27.48% remain stronger than industry benchmark medians.<\/li>\n<li>The company operates in Healthcare and Pharmaceuticals &amp; Drugs, where peer comparison remains relevant after sharp daily moves.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Gujarat_Themis_Biosyn\"><\/span><strong>About Gujarat Themis Biosyn<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Gujarat Themis Biosyn is part of the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. In this analysis, it is assessed against a same-industry universe of 201 listed companies. Based on the supplied data, it is best viewed as a Mid Cap pharmaceutical stock with above-median scale, premium valuation and stronger-than-average profitability.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Gujarat_Themis_Biosyn_Share_Price_on_Univest\"><\/span><strong>Track Gujarat Themis Biosyn Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use<a href=\"https:\/\/univest.in\/stocks\/gujthem\/gujarat-themis-biosyn-ltd-share-price-today\">Gujarat Themis Biosyn (GUJTHEM) live share-price page<\/a>,<a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>,<a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a>to review live stock data, top decliners and related market analysis.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong>&nbsp;Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Gujarat_Themis_Biosyn_Share_Price_falling_today\"><\/span><strong>Why is Gujarat Themis Biosyn Share Price falling today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;The stock was down 5.07% in the session, moving from Rs 453.10 to Rs 430.15. The supplied data confirms the decline but does not identify a company-specific reason. The intraday range extended from Rs 427.55 to Rs 463.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Gujarat_Themis_Biosyn_Share_Price_today\"><\/span><strong>What is Gujarat Themis Biosyn Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;At the time of the update, the stock was trading at Rs 430.15, which was Rs 22.95 below the previous close of Rs 453.10. The stock moved 5.07% lower during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_the_intraday_move_show_for_GUJTHEM\"><\/span><strong>What does the intraday move show for GUJTHEM?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;GUJTHEM opened at Rs 463.00, which was also the day\u2019s high, then moved down to Rs 427.55 before trading at Rs 430.15. That pattern indicates weakness after the opening level.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_is_the_stock_valued_versus_its_industry\"><\/span><strong>How is the stock valued versus its industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Its P\/E ratio of 121.12 is above the same-industry median of 32.19 and average of 49.13. Its P\/B ratio of 5.62 is also above the benchmark median of 3.05 and average of 4.44.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Are_its_profitability_ratios_strong\"><\/span><strong>Are its profitability ratios strong?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Based on the supplied data, ROE is 21.69% and ROCE is 27.48%. Both are above the same-industry medians and averages listed in the benchmark snapshot. The relevant peer median ROE is 11.82%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_it_compare_with_major_pharma_peers\"><\/span><strong>How does it compare with major pharma peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;The stock has a higher P\/E than Sun Pharma, Divi&#39;s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla. Its ROCE of 27.48% is stronger than each of those five peers in the supplied comparison.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gujarat Themis Biosyn Share Price falls to Rs 430.15. marking a 5.07% fall today. Market cap stands at Rs 5,897.17 crore.<\/p>\n","protected":false},"author":29,"featured_media":238524,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-238526","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["238524"],"rank_math_title":["Gujarat Themis Biosyn Share Price Today Falls 5.07%"],"rank_math_description":["Gujarat Themis Biosyn Share Price fell 5.07% to Rs 430.15. Track today's price action, valuation, fundamentals, sector and peer analysis."],"rank_math_focus_keyword":["Gujarat Themis Biosyn Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Gujarat_Themis_Biosyn_GUJTHEM_Share_Price_Falls_507_Today_bearish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/238526","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=238526"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/238526\/revisions"}],"predecessor-version":[{"id":238528,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/238526\/revisions\/238528"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/238524"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=238526"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=238526"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=238526"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}